Donati Danilo, Vita Fabio, Amoruso Vincenza, Origlio Flavio, Tedeschi Roberto, Castagnini Francesco, Stella Salvatore Massimo, Miceli Marco, Faldini Cesare, Galletti Stefano
Physical Therapy and Rehabilitation Unit, Policlinico di Modena, 41125 Modena, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Diagnostics (Basel). 2024 Sep 20;14(18):2087. doi: 10.3390/diagnostics14182087.
Low back pain is a prevalent condition affecting 60-85% of individuals during their lifetime. Despite various proposed mechanisms, the etiology of low back pain remains unclear. This study aims to evaluate the effectiveness of combining ultrasound-guided infiltrations with early rehabilitation in reducing pain and improving functional limitations in patients with chronic nonspecific low back pain. A retrospective observational study was conducted, reviewing data from January to April 2024 involving 40 patients with chronic nonspecific low back pain. Each patient received two cycles of ultrasound-guided lidocaine and corticosteroid infiltrations at the level of the posterior lower iliac spine, followed by 10 rehabilitation sessions. Patients were assessed at baseline (T0), after the first treatment cycle (T1), and after the second cycle (T2) using the Oswestry Disability Index, Quebec Back Pain Disability Scale, Roland Disability Questionnaire, and Numeric Rating Scale. Significant improvements were observed across all assessment scales. The ODI scores decreased from 33.5 at baseline to 3.5 after treatment ( < 0.001). Similar reductions were noted in the QBPDS (from 61.5 to 10.3), RDQ (from 18 to 3.4), and NRS (from 7.4 to 1.3). The combination of ultrasound-guided infiltrations and early rehabilitation resulted in a significant reduction in pain and disability, with the most notable improvements occurring after the second treatment cycle. The integration of ultrasound-guided infiltrations with early rehabilitation is highly effective in managing chronic nonspecific low back pain, significantly reducing both pain and functional limitations.
腰痛是一种常见病症，一生中影响60 - 85%的人。尽管提出了各种机制，但腰痛的病因仍不清楚。本研究旨在评估超声引导下注射联合早期康复在减轻慢性非特异性腰痛患者疼痛和改善功能受限方面的有效性。进行了一项回顾性观察研究，回顾了2024年1月至4月期间40例慢性非特异性腰痛患者的数据。每位患者在髂后下棘水平接受两个周期的超声引导下利多卡因和皮质类固醇注射，随后进行10次康复治疗。使用Oswestry功能障碍指数、魁北克腰痛残疾量表、罗兰残疾问卷和数字评定量表在基线（T0）、第一个治疗周期后（T1）和第二个周期后（T2）对患者进行评估。在所有评估量表上均观察到显著改善。ODI评分从基线时的33.5降至治疗后的3.5（<0.001）。QBPDS（从61.5降至10.3）、RDQ（从18降至3.4）和NRS（从7.4降至1.3）也有类似下降。超声引导下注射联合早期康复导致疼痛和残疾显著减轻，在第二个治疗周期后改善最为显著。超声引导下注射与早期康复相结合在管理慢性非特异性腰痛方面非常有效，可显著减轻疼痛和功能受限。
